🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tomasz Kluz

Fryderyk Chopin University of Music

ORCID: 0000-0002-4798-3986

Also affiliated with Institute of Medical Sciences, University of Rzeszów

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.751Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology Clinical Research(2023)10.1002/cjp2.311
Top 27%
0.751DataRank
Top 27%28 citations

Eunyoung Kang, Ashley Weir, Peter Rambau, Cheng‐Han Lee, Gregg Nelson +95 more

Papers

Driven by 6 papers — median percentile 73. Top paper: “p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study”.

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology Clinical Research(2023)10.1002/cjp2.311
Top 27%
0.751DataRank
Top 27%28 citations

Eunyoung Kang, Ashley Weir, Peter Rambau, Cheng‐Han Lee, Gregg Nelson +95 more

Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

medRxiv(2023)10.1101/2023.11.09.23298321
N/A
0.269DataRank · unranked
5 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +94 more

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3552
N/A
0DataRank · unranked
14 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +93 more

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.05.013
N/A
0DataRank · unranked
2 citations

Lauren Borho, Sarah E. Taylor, Linda E Kelemen, Anna deFazio, Penelope M. Webb +64 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma

medRxiv(2025)10.1101/2025.09.17.25335919
N/A
0DataRank · unranked
0 citations

Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey +95 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Research Square(2025)10.21203/rs.3.rs-7572112/v1
N/A
0DataRank · unranked
0 citations

Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana +95 more